| ID | 1702 |
| No | 1702 |
| Brand Name | LUCICAPIVA |
| Ingredients | CAPAVASERTIB 200 MG |
| Dosage Form | TABLET |
| Primary Packaging | BOTTLE |
| Storage | |
| Shelf Life | 2 YEARS |
| Pack Size | BOX OF 64'S/BOTTLE |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF ADULT PATIENTS WITH HORMONE RECEPTOR POSITIVE, HYMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE, LOCALLY ADVANCED OR METASTATIC BREAST CANCER WITH ONE OR MORE PIK3CA/AKT1/PTEN ALTERATION FOLLOWING PROGRESSION ON AT LEAST ONE ENDOCRINE BASED REGIMENT ON THE METASTATIC SETTING OR RECURRENT ON OR WITHIN 12 MONTHS OF CONPLETING ADJUVANT THERAPY |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | YELLOW, BICONVEX FILM COATED TABLET, WITH LETTER LUCIUS ON ONE SIDE AND PLAIN ON THE OTHER SIDE |
| Note | |
| License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
| Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 08 L 1160/24 |
| FDD Registration Date | 21/08/2024 |
| Expiry Date | 20/08/2027 |